Free Shipping on orders over $250
Product Name
CJC/IPA (No DAC)
$180.00
A dual-peptide research blend investigated for GHRH and growth-hormone-secretagogue receptor signaling and related endocrine pathways.
Research Focus
GHRH Signaling • Ghrelin-Receptor Signaling • Growth Hormone Axis • Pituitary Biology • Endocrine Research
Research Disclaimer: Avante Peptides products are for laboratory and scientific research only and are not intended for human consumption, veterinary use, clinical application, or therapeutic treatment. All research must be conducted by qualified professionals in appropriate laboratory environments.
CJC-1295 (No DAC) + Ipamorelin is a combination of two research peptides investigated for their interaction with distinct signaling pathways involved in the growth hormone axis.
CJC-1295 (No DAC), commonly referred to as Modified GRF (1-29), is a modified analog of growth hormone-releasing hormone (GHRH) studied for its interaction with GHRH-receptor signaling. Ipamorelin is a growth hormone secretagogue studied for its interaction with the ghrelin receptor (GHS-R1a).
Laboratory research involving these compounds examines the relationship between GHRH and ghrelin-receptor signaling, pituitary signaling mechanisms, endocrine pathway regulation, and growth-hormone-axis biology.
| Attributes | Value |
|---|---|
| Dimensions | 0.66 × 0.66 × 1.5 in |
| Strength |
20mg |
| Research Focus |
GHRH Signaling • Ghrelin-Receptor Signaling • Growth Hormone Axis • Pituitary Biology • Endocrine Research |